CSPC Pharmaceutical

News

AZ forges ever-closer ties with China's CSPC Pharma

AstraZeneca has returned to China's CSPC Pharma to fill its R&D pipeline, reaching a new $1.77bn agreement to develop drugs for kidney diseases.

News

AZ deepens Chinese ties, signs $18.5bn CSPC obesity deal

AstraZeneca deepens ties with China, pledging $15bn in investment and signing a big $18.5bn alliance with CSPC Pharma for obesity and diabetes drugs.

News

AZ taps Chinese firm CSPC's AI acumen in $5.2bn+ alliance

AstraZeneca taps China's CSPC Pharma for new drug candidates a second time – and the latest AI-focused alliance is a big one.

News

AZ extends cardiovascular pipeline with $2bn CSPC deal

AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceut

AZ forges ever-closer ties with China's CSPC Pharma

AZ deepens Chinese ties, signs $18.5bn CSPC obesity deal

AZ taps Chinese firm CSPC's AI acumen in $5.2bn+ alliance

AZ extends cardiovascular pipeline with $2bn CSPC deal

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

CSPC Pharmaceutical

Editor's Picks